new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Ranbaxy Laboratories Limited
Ranbaxy Laboratories Limited Inc
  

Ranbaxy Laboratories Limited patents

Recent patent applications related to Ranbaxy Laboratories Limited. Ranbaxy Laboratories Limited is listed as an Agent/Assignee. Note: Ranbaxy Laboratories Limited may have other listings under different names/spellings. We're not affiliated with Ranbaxy Laboratories Limited, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Ranbaxy Laboratories Limited-related inventors




Date Ranbaxy Laboratories Limited patents (updated weekly) - BOOKMARK this page
10/06/16Oral dispersible composition of a dpp-iv inhibitor
06/30/16Process for the preparation of malic acid salt of sunitinib
05/26/16Low dose pharmaceutical composition of doxycycline
01/21/16Stable dosage forms of imatinib mesylate
11/26/15Process for the preparation of dasatinib and its intermediates
11/19/15Saxagliptin salts
11/19/15Process for the preparation of pazopanib or salts thereof
11/05/15Pharmaceutical compositions of rifaximin
10/22/15Process for the preparation of rivaroxaban and intermediates thereof
10/15/15Process for the preparation of polymorphs of doripenem
09/03/15Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
08/20/15Osmotic floating tablets
08/20/15Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
08/13/15Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
08/06/15Process for the preparation of rivaroxaban
07/16/15Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate
06/25/15Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
06/04/15Stable oral pharmaceutical composition of solifenacin
05/14/15Multilayered dosage form
05/14/15Process for the preparation of rivaroxaban
04/23/15Ascorbic acid salt of sunitinib
04/23/15Process for the preparation of asenapine maleate
04/23/15Pure crystalline form ii of l-malic acid salt of sunitinib and processes for its preparation
03/12/15Process for the preparation of crystalline vilazodone hydrochloride
01/29/15Taste masked dispersible tablets
01/29/15Febuxostat solid dispersion
01/29/15Stabilized controlled-release pharmaceutical composition comprising gliclazide
01/22/15Solid dispersions of sitagliptin and processes for their preparation
01/22/15Gastroretentive tablets
01/08/15Process for the preparation of azilsartan medoxomil or pharmaceutically acceptable salts thereof
12/25/14In-situ multilayered tablet technology
12/25/14Amorphous vilazodone hydrochloride, a process for its preparation and pharmaceutical compositions thereof
12/25/14Pregabalin gr tablets
12/04/14Process for the preparation of dexlansoprazole
09/25/14Process for the preparation of solid dispersion of lopinavir and ritonavir
09/18/14Gastroretentive dosage system and process of preparation thereof
07/03/14Crystalline forms of bosentan salts and processes for their preparation
07/03/14Crystalline forms of bosentan salts and processes for their preparation
06/26/14Multiparticulate extended-release composition of mesalamine
05/29/14Matrix metalloproteinase inhibitors
05/22/14Process for the preparation of an intermediate of tadalafil
05/15/14Stable oral benzimidazole compositions and process of preparation thereof
04/24/14Multi-layered, multiple unit pharmaceutical compositions
04/03/14Febuxostat compositions
03/06/14Topical pharmaceutical composition comprising nanonized silver sulfadiazine
10/17/13Polymorphs of sorafenib acid addition salts
10/10/13Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
09/26/13Pharmaceutical composition comprising phentermine and topiramate
09/26/13Pharmaceutical compositions containing a biguanide and a low dose antidiabetic agent
09/26/13Process for the preparation of pure meropenem trihydrate
09/19/13Process for the preparation of febuxostat
08/22/13Pharmaceutical composition of atorvastatin and ezetimibe
08/15/13Sorafenib dimethyl sulphoxide solvate
08/15/13Crystalline forms of l-malic acid salt of sunitinib
08/08/13Process for the preparation of dexlansoprazole
08/08/13Processes for reducing impurities in lacosamide
08/01/13Extended release pharmaceutical dosage forms of carbidopa and levodopa and process of preparation thereof
08/01/13Process for the preparation of crystalline forms of dexlansoprazole
08/01/13Salts of dexlansoprazole and their preparation
08/01/13Process for the preparation of crystalline form ii of l-malic acid salt of sunitinib
07/25/13Solid dosage forms of hiv protease inhibitors
07/11/13Taste masked dosage forms of bitter tasting anti-retroviral drugs
06/13/13Novel intermediates for the preparation of hmg-coa reductase inhibitors
05/23/13Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
05/16/13Process for the direct preparation of malic acid salt of sunitinib
Patent Packs
04/04/13Process for the preparation of bortezomib
04/04/13Processes for preparation of polymorphic forms of lacosamide
03/21/13Process for stereoselective synthesis of 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
01/03/13Sorafenib ethylsulfonate salt, process for preparation and use
01/03/13Process for the preparation of sorafenib tosylate
12/27/12Pharmaceutical composition of donepezil
12/06/12Processes for the preparation of cinacalcet
11/29/12Processes for the preparation of erlotinib hydrochloride form a and erlotinib hydrochloride form b
11/15/12Multi-layered, multiple unit pharmaceutical compositions
11/08/12Delayed release pharmaceutical composition of mesalamine
11/08/12Crystalline forms of bosentan salts and processes for their preparation
11/01/12Process for the preparation of crystalline aprepitant having form i content
10/25/12Processes for the preparation of form i and form ii of palonosetron hydrochloride
10/25/12Process for the preparation of crystalline form i of l-malic acid salt of sunitinib
10/18/12Polymorphs of sorafenib acid addition salts
Patent Packs
10/11/12Liquid dosage forms of isotretinoin
10/11/12Topical retnoid solutions
08/30/12Process for the preparation of a crystalline form of lenalidomide
08/30/12Salts of sunitinib
08/30/12Process for the preparation of fosamprenavir calcium
08/16/12Crystalline form of fosamprenavir calcium
07/26/12Processes for the preparation of vardenafil
07/26/12Process for the preparation of valganciclovir hydrochloride
07/19/12Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
07/19/12Process for the preparation of lenalidomide
07/19/12Process for the preparation of olmesartan medoxomil
07/19/12Polymorphic form of olmesartan medoxomil
07/12/12Polymorphic form of toremifene citrate and process for its preparation
07/12/12Process for the preparation of 1, 2, 4-trioxolane antimalarials
06/28/12Pulsatile release pharmaceutical formulation of dexlansoprazole
06/28/12Stable oral pharmaceutial composition of atorvastatin
06/14/12Valacyclovir formulations
05/31/12Amorphous fosamprenavir calcium
05/03/12Anti dengue activity of cissampelos pareira extracts
04/26/12Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
04/26/12Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof
04/26/12Process for the preparation of desloratadine
04/19/12Pharmaceutical compositions containing a biguanide and a thiazolidinedione
04/19/12Oral metaxalone compositions
03/22/12Process for the preparation of quetiapine fumarate
02/02/12Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
01/05/12Levetiracetam controlled release composition
01/05/12Intermediate compounds and their use in preparation of lacosamide
09/29/11Ciprofloxacin oral suspension
09/15/11Process for preparation of amorphous lopinavir
Social Network Patent Pack
09/08/11Fenofibrate compositions
08/25/11Process for the preparation of ziprasidone
08/04/11Substituted pyrrole derivatives and their use as hmg-co inhibitors
08/04/11Substituted pyrrole derivatives and their use as hmg-co inhibitors
07/21/11Process for the preparation of 3,4-epoxy-2-amino-1-substituted butane derivatives and intermediate compounds thereof
07/14/11Process for preparing a carbapenem antibiotic composition
07/07/11Benzothiazoles and aza-analogues thereof use as antibacterial agents
06/02/11Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
05/26/11Process for the preparation of dispiro 1,2,4-trioxolane antimalarials (oz277)
04/07/11Process for the preparation of sterile doripenem
Patent Packs
03/24/11Process for the preparation of efavirenz
03/03/11Modified release lamotrigine tablets
02/10/11Solid dosage forms of hiv protease inhibitors
02/10/11Process for the preparation of pure prulifloxacin
01/27/11Multilayered modified release formulation comprising amoxicillin and clavulanate
01/27/11Inhibitors of phosphodiesterase type-iv
12/23/10Crystalline form i of lamivudine and its preparation
12/09/10Process and intermediates for the preparation of substituted 1,3-oxathiolanes, especially lamivudine
12/09/10Process for the preparation of substituted 1,3-oxathiolanes
12/02/10Process for preparation of piperidine carboxylic acid
11/25/10Controlled release lamotrigine formulations
11/18/10Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
11/04/10Process for the preparation enantiomerically pure salts of n-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine
10/21/10Packaging for sirolimus and composition thereof
09/30/10Extended release tablets of nisoldipine
09/09/10Process for the preparation of intermediates of tetracyclic compounds
08/19/10Process for the preparation of pantoprazole sodium and pantoprazole sodium sesquihydrate
07/15/10Stabilized pharmaceutical compositions comprising atorvastatin
07/15/10Bilayered tablet comprising niacin and hmg-coa reductase inhibitor
06/17/10Modified-release formulations of azabicyclo derivatives
06/10/10Extended release tablet formulation of niacin
06/10/10Novel polymorphic forms of milnacipran hydrochloride
05/13/10Standarized bioactive herbal extracts
05/06/10Process for the preparation of crystals of prulifloxacin
04/22/10Oily suspension of atovaquone
02/04/10Phosphodiesterase inhibitors
12/31/09Muscarinic receptor antagonists
05/07/09Process for preparation of (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
04/23/09Muscarinic receptor antagonists
02/05/09Salts of hmg-coa reductase inhibitors and use thereof
Patent Packs
05/06/10Derivatives of pentose monosaccharides as anti-inflammatory compounds
03/19/09Derivatives of pentose monosaccharides as anti-inflammatory compounds







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ranbaxy Laboratories Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ranbaxy Laboratories Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';